Glendon E. French III - 02 Mar 2026 Form 4 Insider Report for Pulmonx Corp (LUNG)

Signature
/s/ David Aaron Lehman, Attorney-in-Fact
Issuer symbol
LUNG
Transactions as of
02 Mar 2026
Net transactions value
-$96,973
Form type
4
Filing time
04 Mar 2026, 19:06:20 UTC
Previous filing
09 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
French Glendon E. III President and CEO, Director C/O PULMONX CORPORATION, 700 CHESAPEAKE DRIVE, REDWOOD CITY /s/ David Aaron Lehman, Attorney-in-Fact 04 Mar 2026 0001805624

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $3,872 -2,708 -0.18% $1.43 1,474,616 02 Mar 2026 Direct F1
transaction LUNG Common Stock Sale $9,634 -6,737 -0.46% $1.43 1,467,879 02 Mar 2026 Direct F2
transaction LUNG Common Stock Sale $83,466 -58,368 -4% $1.43 1,409,511 02 Mar 2026 Direct F3
holding LUNG Common Stock 742,998 02 Mar 2026 By trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F3 Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of December 1, 2025.
F4 The shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust UA DTD 08/29/2012, of which the reporting person and his spouse are trustees and beneficiaries.